期刊文献+

儿童心肌病遗传代谢性病因的诊断建议 被引量:19

原文传递
导出
摘要 随着临床诊断技术的进展,目前25%~43%的儿童心肌病能够明确病因,其中先天性代谢缺陷(inbornelTorsofmetabolism,IEM)占11%~34%。由于部分IEM有针对性治疗,经过治疗有可能逆转、阻止或延缓心肌病变并改善预后,因此早期识别及明确诊断非常重要。根据国内外相关的研究资料,经过专家讨论达成共识,提出本建议,旨在指导临床医师对此类患儿选取合适的检查手段,早期明确病因并给予相应治疗。
出处 《中华儿科杂志》 CAS CSCD 北大核心 2013年第5期385-388,共4页 Chinese Journal of Pediatrics
  • 相关文献

参考文献27

  • 1Arola LC, Jokinen E, Ruuskanen O, et al. Epidemiology ot idiopathic cardiomyopathies in children and adolescents: a nationwide study in Finland. Am J Epidemiol, 1997, 146: 385- 393.
  • 2Nugent AW, Daubeney PEF, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med, 2003, 348: 1639-1647.
  • 3Lipshultz SE, Sleeper L, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two region of the United States. N Engl J Med, 2003, 348 : 1647-1655.
  • 4Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA, 2006, 296 : 1867-1876.
  • 5Colan SD, Lipshultz SE, Lowe AM, et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children. Circulation, 2007, 115:773-781.
  • 6Cox GF, Sleeper LA, Lowe AM, et al. Factors associated with establishing a causal diagnosis for children with cardiomyopathy. Pediatrics, 2006, 118 : 1519-1531.
  • 7Wilkinson JD, Sleeper LA, Alvarez JA, et al. The Pediatric Cardiomyopathy Registry : 1995-2007. Prog Pediatr Cardiol, 2008, 25.- 31-36.
  • 8Hershberger RE, Lindenfeld J, Mestroni L, et al. Genetic evaluation of cardiomyopathy--a Heart Failure Society of America practice guideline. J Card Fail, 2009, 15: 83-97.
  • 9Applegarth DA, Toone JR, Lowry RB. Incidence of inborn errors of metabolism in British Columbia, 1969-1996. Pediatrics, 2000, 105 : el0.
  • 10Van Den Hout HM, Hop W, van Diggelen OP, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics, 2003, 112: 332- 340.

二级参考文献56

  • 1Danon MJ, Oh SJ, DiMauro S, et al. Lysosomal glycogen storage disease with normal acid maltase. Neurology, 1981, 31:51-57.
  • 2Nishino I, Fu J, Tanji K, et al. Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease). Nature, 2000, 406:906-910.
  • 3Sugie K, Yamamoto A, Murayama K, et al. Clinicopathological features of genetically confirmed Danon disease. Neurology, 2002, 58 : 1773-1778.
  • 4Arad M, Maron BJ, Gorham JM, et al. Glycogen storage diseases presenting as hypertrophic cardiomyopathy. N Engl J Med, 2005, 352:362-372.
  • 5Wallace DC. Mitochondrial defects in cardiomyopathy and neuromuscular disease. Am Heart J, 2000, 139 (2Pt3) :70-85.
  • 6Taylor GP. Neonatal mitochondrial cardiomyopathy. Pediatr Dev Pathol, 2004, 7:620-624.
  • 7Holmgren D, Wahlander H, Eriksson BO, et al. Cardiomyopathy in children with mitochondrial disease ; clinical course and cardiological findings. Eur Heart J, 2003, 24:280-288.
  • 8Scaglia F, Towbin JA, Craigen WJ, et al. Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease. Pediatrics, 2004, 114:925-931.
  • 9Clarke JT. Narrative review: fabry disease. Ann Intern Med, 2007, 146:425-433.
  • 10Anderson S, Bankier AT, Barrell BG, et al. Sequence and organization of the human mitochondrial genome. Nature, 1981, 290:457-465.

共引文献14

同被引文献194

引证文献19

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部